EMCDDA Home
  • EN
Search

Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (iii) New inpatient clients, ratio of males to females by country and primary drug

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsGender and drug known
Belgium5.45.14.42.0::12.8:223
Bulgaria6.5:::::::162
Czech Republic 2.10.31.60.8:1.53.01.0947
Denmark1.82.02.3:::3.5:52
Germany4.59.17.11.1::9.02.5865
Estonia:::::::::
Ireland2.34.19.02.0::4.9:506
Greece7.34.6:1.0::6.70.0801
Spain:::::::::
France4.0:::::::11
Italy:::::::::
Cyprus(1)4.3:::::::23
Latvia:::::::::
Lithuania:::::::::
Luxembourg :::::::::
Hungary1.0::0.1::3.01.037
Malta:::::::::
Netherland 5.23.91.40.85.35.02.91.5505
Austria(2)3.7::2.0::2.5:185
Poland:::::::::
Portugal:::::::::
Romania6.00.0:0.4::6.21.5547
Slovenia:::::::::
Slovakia2.90.03.30.5:4.56.3:247
Finland1.7:1.10.80.0:3.0:102
Sweden1.54.82.41.1::7.21.6708
United Kingdom 2.42.31.22.0:1.03.10.7960
Croatia3.3::0.7::8.32.4262
Turkey17.117.53.42.4:14.214.69.01456
Norway:::::::::
Total4.34.12.10.97.510.85.92.02.5
Total base390170211264963420118113288599

Notes:

 : Indicates no data are available                     

 Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented. 

 (1) For Cocaine 6 males have been reported. 

 (2) For Cocaine 20 males have been reported 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Thursday, 30 June 2011